Senior insider sale
President and CEO at ATARA BIOTHERAPEUTICS, INC. — senior position signals high conviction
$18.2K
3.35K shares
What this filing means
NGUYEN ANHCO plans to sell 3.35K shares of ATARA BIOTHERAPEUTICS, INC. valued at approximately $18.2K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/2/2026ACC: 0000905148-26-001102
DirectorOfficer· President and CEO
Since Mar 2026
3.35K
Shares to sell
$18.2K
Approx. market value
7.79K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Settlement of vested RSUs issued under an S-8 Registration Plan
Equity compensation for services rendered
3/1/2026
7.79KTotal acquired7.79K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/1/2026 | Settlement of vested RSUs issued under an S-8 Registration Plan Equity compensation for services rendered | 7.79K | — |
| Total | 7.79K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
3.35K
Market value
$18.2K
3/2/2026
Total
Units
3.35K
Value
$18.2K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
3/2/2026 | 3.35K | $18.2K | NASDAQ | Planned |
| Total | 3.35K | $18.2K | ||